Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

National and Sub-National Delivery of Balanced Energy and Protein (BEP) Supplements to Pregnant and Lactating Women in LMICs: Lessons from Multi-Country Implementation Case Studies.

Nutrients·2026
Same author

Platelets regulate glioblastoma growth and immunity via sex-dependent PAR4 - Estrogen receptor beta signaling.

bioRxiv : the preprint server for biology·2026
Same author

Intraoperative visual evoked potentials and electroretinographic monitoring during endoscopic transsphenoidal surgery.

Brain & spine·2026
Same author

Signal, Speculation, and Standards of Proof in Iatrogenic Alzheimer Disease.

JAMA neurology·2026
Same author

Genetic Creutzfeldt-Jakob disease linked to the E200K mutation: a large cohort study.

Acta neuropathologica·2026
Same author

A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma.

Neuro-oncology·2025
Same journal

Extent of resection as an independent predictor of survival for patients with glioblastoma as defined by the new WHO 2021 classification.

Journal of neurosurgery·2026
Same journal

Surgical treatment of schwannomas around the tarsal tunnel: a case series of 40 patients and systematic review of the literature.

Journal of neurosurgery·2026
Same journal

Direct targeting for focused ultrasound thalamotomy in the treatment of movement disorders.

Journal of neurosurgery·2026
Same journal

Development and internal validation of the Meningioma Functional Outcome Risk and Counseling Estimator 6 score, a point-based prognostic tool for predicting 6-week functional independence after intracranial meningioma resection.

Journal of neurosurgery·2026
Same journal

Connectional anatomy of the cerebellum: dentate nucleus and cerebellar peduncles from a surgical perspective.

Journal of neurosurgery·2026
Same journal

Press releases in neurosurgery: is scientific accuracy compromised in public reporting of neurosurgery research?

Journal of neurosurgery·2026
See all related articles

Related Experiment Video

Updated: Mar 21, 2026

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
09:43

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

8.5K

An IDH1-mutated primary gliosarcoma: case report.

Jason K Hsieh1,2, Christopher S Hong3, Sunil Manjila4

  • 1Case Western Reserve University School of Medicine, Cleveland.

Journal of Neurosurgery
|May 7, 2016
PubMed
Summary
This summary is machine-generated.

This study reports a rare primary gliosarcoma with an isocitrate dehydrogenase-1 (IDH1) mutation. This unusual genetic-histological finding in a high-grade glioma may indicate differences from typical glioblastoma.

Keywords:
EGFR = epidermal growth factor receptorGFAP = glial fibrillary acidic proteinIDH1 = isocitrate dehydrogenase-1glioblastomagliosarcomaisocitrate dehydrogenaseoncology

More Related Videos

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

1.3K
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

8.4K

Related Experiment Videos

Last Updated: Mar 21, 2026

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
09:43

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

8.5K
A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

1.3K
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

8.4K

Area of Science:

  • Neuro-oncology
  • Cancer Genetics
  • Pathology

Background:

  • Gliosarcoma is a rare, aggressive variant of glioblastoma (Grade 4 glioma).
  • Isocitrate dehydrogenase (IDH) mutations are typically associated with lower-grade gliomas and improved survival.
  • IDH mutations are less commonly found in glioblastoma.

Observation:

  • A 75-year-old male presented with seizures and a left parietal enhancing mass on MRI.
  • Surgical resection revealed a high-grade glioma with sarcomatous components.
  • Immunohistochemistry confirmed the presence of the IDH1 R132H mutation.

Findings:

  • This case represents a primary gliosarcoma harboring an IDH1 mutation.
  • This is only the second reported instance of a primary gliosarcoma with an IDH mutation.
  • The tumor exhibited both glial and sarcomatous features.

Implications:

  • This rare genetic-histological combination challenges current understanding of glioma classification.
  • Potential differences between IDH-mutated gliosarcoma and IDH-mutated glioblastoma warrant further investigation.
  • Further research may refine diagnostic criteria and therapeutic strategies for rare gliomas.